# Quince Therapeutics

**Canonical:** https://apis.io/providers/quince-therapeutics/  
**Website:** https://irulya.com/  
**APIs profiled:** 0

IRulya Therapeutics Inc., formerly Quince Therapeutics, focuses on developing pulmonary medicines that target disease biology directly in the lungs. Founded to deliver innovative therapies for lung diseases, the company aims to bring novel treatments to patients with unmet needs, leveraging its expertise in drug discovery and development.

## Kin Score — 5.7 / 100 (minimal)

Scored 2026-10-31 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 42.9 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 7.8 (matched via tags).

## Agent readiness — 3.1 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | documented |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Quince Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Pulmonary Therapeutics, mTOR, Clinical Trials

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/quince-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.